ACHC logo

Acadia Healthcare Company Inc. (ACHC)

$24.99

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ACHC

Market cap

$2.30B

EPS

-12.2

P/E ratio

--

Price to sales

0.71

Dividend yield

--

Beta

0.690577

Price on ACHC

Previous close

$24.99

Today's open

$25.06

Day's range

$24.77 - $25.50

52 week range

$11.43 - $30.20

Profile about ACHC

CEO

Debbie Osteen

Employees

25000

Headquarters

Franklin, TN

Exchange

Nasdaq Global Select

Shares outstanding

91967027

Issue type

Common Stock

ACHC industries and sectors

Healthcare

Healthcare Providers & Services

News on ACHC

These 10 Stocks Are Getting Crushed By Short Sellers Right Now

Short sellers are piling into a wide-ranging group of names, with the latest Benzinga Pro data showing elevated bearish positioning across 10 stocks with short interest ranging from 37% to 87%.

news source

Benzinga • Jun 11, 2026

news preview

Why Is Acadia Healthcare (ACHC) Down 8.2% Since Last Earnings Report?

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • May 29, 2026

news preview

Acadia Healthcare Stock Soars 82% YTD: Time to Hold or Fold?

ACHC shares surge 82% YTD while it expands bed capacity, boosts cash flow and rides on rising behavioral health demand.

news source

Zacks Investment Research • May 18, 2026

news preview

Acadia Healthcare Q1 Earnings Beat Estimates on Rising Patient Days

ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.

news source

Zacks Investment Research • May 4, 2026

news preview

Acadia Healthcare Company, Inc. (ACHC) Q1 2026 Earnings Call Transcript

Acadia Healthcare Company, Inc. (ACHC) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 1, 2026

news preview

Acadia Healthcare: Why I Am Selling The Rally (Rating Downgrade)

Acadia Healthcare Company, Inc. is downgraded to Sell due to persistent structural issues and a sharp valuation increase. Despite CEO change and capex cuts, ACHC faces a 200+ bps margin disadvantage from elevated insurance costs and rising claim frequency. ACHC's reliance on Medicaid (60.7% of revenue) is at risk from OBBBA, with reimbursement rates set to decline after 2028.

news source

Seeking Alpha • Apr 30, 2026

news preview

Acadia Healthcare Announces First Quarter 2026 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per patient day of 5.6% and an increase in patient days of 1.6% Net income attributabl.

news source

Business Wire • Apr 29, 2026

news preview

Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.4 per share a year ago.

news source

Zacks Investment Research • Apr 30, 2026

news preview

Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's firs.

news source

Business Wire • Apr 23, 2026

news preview

David Einhorn signals caution as his hedge fund Greenlight prioritizes capital protection

Greenlight Capital's David Einhorn warned that investors may be underestimating potential downside risks. "It probably won't surprise anyone that we are again putting capital preservation at the top of our priorities," Einhorn said in his latest investor letter.

news source

CNBC • Apr 14, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Acadia Healthcare Company Inc.

Open an M1 investment account to buy and sell Acadia Healthcare Company Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ACHC on M1